Opiant Pharmaceuticals, Inc.
| (b) | Address of Issuer’s Principal Executive Offices |
233 Wilshire Blvd., Suite 400, Santa Monica, CA 90401
This Schedule 13G is being filed on behalf of Western Standard, LLC, Eric D. Andersen, and Western Standard Partners, L.P. (each, a “Reporting Person”).
| (b) | Address of Principal Business office or, if None, Residence |
For each Reporting Person,
5900 Wilshire Blvd, Suite 650, Los Angeles, California 90036
Western Standard, LLC is a California limited liability company
Western Standard Partners, L.P. is a Delaware limited partnership
Mr. Andersen is a United States citizen
| (d) | Title of Class of Securities |
Common Stock, par value $0.001 per share
683750103
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) | ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c). |
| (b) | ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
| (c) | ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
| (d) | ☐ Investment company registered under section 8 of the Investment Company Act (15 U.S.C. 80a-8). |
| (e) | ☐ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E). |